Insider Selling: UnitedHealth Group Incorporated (UNH) Director Sells $96,440.71 in Stock

UnitedHealth Group Incorporated (NYSE:UNH) Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.23 on Friday, hitting $209.90. The company’s stock had a trading volume of 1,881,773 shares, compared to its average volume of 3,109,878. The firm has a market capitalization of $204,130.00, a PE ratio of 22.05, a PEG ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $148.56 and a 12 month high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.17 earnings per share. analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 34.09%.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://ledgergazette.com/2017/11/18/insider-selling-unitedhealth-group-incorporated-unh-director-sells-96440-71-in-stock.html.

Several institutional investors and hedge funds have recently modified their holdings of UNH. Capital International Investors increased its position in shares of UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after acquiring an additional 3,304,902 shares during the last quarter. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares during the last quarter. Harbour Capital Advisors LLC increased its position in shares of UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the last quarter. Institutional investors own 86.00% of the company’s stock.

UNH has been the subject of several recent research reports. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley raised their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Finally, Leerink Swann restated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $216.65.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply